UniProt ID | NPM_HUMAN | |
---|---|---|
UniProt AC | P06748 | |
Protein Name | Nucleophosmin | |
Gene Name | NPM1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 294 | |
Subcellular Localization | Nucleus, nucleolus . Nucleus, nucleoplasm . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Generally nucleolar, but is translocated to the nucleoplasm in case of serum starvation or treatment with anticancer drugs. Has been found | |
Protein Description | Involved in diverse cellular processes such as ribosome biogenesis, centrosome duplication, protein chaperoning, histone assembly, cell proliferation, and regulation of tumor suppressors p53/TP53 and ARF. Binds ribosome presumably to drive ribosome nuclear export. Associated with nucleolar ribonucleoprotein structures and bind single-stranded nucleic acids. Acts as a chaperonin for the core histones H3, H2B and H4. Stimulates APEX1 endonuclease activity on apurinic/apyrimidinic (AP) double-stranded DNA but inhibits APEX1 endonuclease activity on AP single-stranded RNA. May exert a control of APEX1 endonuclease activity within nucleoli devoted to repair AP on rDNA and the removal of oxidized rRNA molecules. In concert with BRCA2, regulates centrosome duplication. Regulates centriole duplication: phosphorylation by PLK2 is able to trigger centriole replication. Negatively regulates the activation of EIF2AK2/PKR and suppresses apoptosis through inhibition of EIF2AK2/PKR autophosphorylation. Antagonizes the inhibitory effect of ATF5 on cell proliferation and relieves ATF5-induced G2/M blockade. [PubMed: 22528486 In complex with MYC enhances the transcription of MYC target genes] | |
Protein Sequence | MEDSMDMDMSPLRPQNYLFGCELKADKDYHFKVDNDENEHQLSLRTVSLGAGAKDELHIVEAEAMNYEGSPIKVTLATLKMSVQPTVSLGGFEITPPVVLRLKCGSGPVHISGQHLVAVEEDAESEDEEEEDVKLLSISGKRSAPGGGSKVPQKKVKLAADEDDDDDDEEDDDEDDDDDDFDDEEAEEKAPVKKSIRDTPAKNAQKSNQNGKDSKPSSTPRSKGQESFKKQEKTPKTPKGPSSVEDIKAKMQASIEKGGSLPKVEAKFINYVKNCFRMTDQEAIQDLWQWRKSL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MEDSMDMD -------CCCCCCCC | 13.41 | 20068231 | |
4 | Phosphorylation | ----MEDSMDMDMSP ----CCCCCCCCCCC | 11.90 | 29255136 | |
10 | Phosphorylation | DSMDMDMSPLRPQNY CCCCCCCCCCCCCCE | 19.27 | 29255136 | |
17 | Phosphorylation | SPLRPQNYLFGCELK CCCCCCCEEEEEEEE | 9.73 | 22617229 | |
24 | Acetylation | YLFGCELKADKDYHF EEEEEEEECCCCCEE | 32.04 | 23954790 | |
24 | Ubiquitination | YLFGCELKADKDYHF EEEEEEEECCCCCEE | 32.04 | - | |
27 | Sumoylation | GCELKADKDYHFKVD EEEEECCCCCEEEEC | 66.11 | - | |
27 | 2-Hydroxyisobutyrylation | GCELKADKDYHFKVD EEEEECCCCCEEEEC | 66.11 | - | |
27 | Acetylation | GCELKADKDYHFKVD EEEEECCCCCEEEEC | 66.11 | 23954790 | |
27 | Succinylation | GCELKADKDYHFKVD EEEEECCCCCEEEEC | 66.11 | 23954790 | |
27 | Sumoylation | GCELKADKDYHFKVD EEEEECCCCCEEEEC | 66.11 | 25218447 | |
27 | Ubiquitination | GCELKADKDYHFKVD EEEEECCCCCEEEEC | 66.11 | 19608861 | |
27 (in isoform 2) | Ubiquitination | - | 66.11 | - | |
29 | Phosphorylation | ELKADKDYHFKVDND EEECCCCCEEEECCC | 18.20 | 20090780 | |
32 | Ubiquitination | ADKDYHFKVDNDENE CCCCCEEEECCCCCC | 35.05 | 21890473 | |
32 | Sumoylation | ADKDYHFKVDNDENE CCCCCEEEECCCCCC | 35.05 | - | |
32 | 2-Hydroxyisobutyrylation | ADKDYHFKVDNDENE CCCCCEEEECCCCCC | 35.05 | - | |
32 | Acetylation | ADKDYHFKVDNDENE CCCCCEEEECCCCCC | 35.05 | 19608861 | |
32 | Malonylation | ADKDYHFKVDNDENE CCCCCEEEECCCCCC | 35.05 | 26320211 | |
32 | Sumoylation | ADKDYHFKVDNDENE CCCCCEEEECCCCCC | 35.05 | 19608861 | |
32 | Ubiquitination | ADKDYHFKVDNDENE CCCCCEEEECCCCCC | 35.05 | 21890473 | |
32 (in isoform 1) | Ubiquitination | - | 35.05 | 21890473 | |
32 (in isoform 2) | Ubiquitination | - | 35.05 | 21890473 | |
32 | Ubiquitination | ADKDYHFKVDNDENE CCCCCEEEECCCCCC | 35.05 | 21890473 | |
43 | Phosphorylation | DENEHQLSLRTVSLG CCCCEEEEEEEEECC | 14.83 | 23401153 | |
45 | Methylation | NEHQLSLRTVSLGAG CCEEEEEEEEECCCC | 29.70 | 115485503 | |
46 | Phosphorylation | EHQLSLRTVSLGAGA CEEEEEEEEECCCCC | 21.53 | 21712546 | |
48 | Phosphorylation | QLSLRTVSLGAGAKD EEEEEEEECCCCCCC | 22.07 | 25159151 | |
54 | 2-Hydroxyisobutyrylation | VSLGAGAKDELHIVE EECCCCCCCEEEEEE | 51.31 | - | |
54 | Acetylation | VSLGAGAKDELHIVE EECCCCCCCEEEEEE | 51.31 | 23954790 | |
54 | Sumoylation | VSLGAGAKDELHIVE EECCCCCCCEEEEEE | 51.31 | - | |
54 | Ubiquitination | VSLGAGAKDELHIVE EECCCCCCCEEEEEE | 51.31 | 21906983 | |
54 (in isoform 1) | Ubiquitination | - | 51.31 | 21890473 | |
54 (in isoform 2) | Ubiquitination | - | 51.31 | 21890473 | |
65 | Sulfoxidation | HIVEAEAMNYEGSPI EEEEEECCCCCCCCE | 4.06 | 30846556 | |
67 | Nitration | VEAEAMNYEGSPIKV EEEECCCCCCCCEEE | 14.47 | - | |
67 | Phosphorylation | VEAEAMNYEGSPIKV EEEECCCCCCCCEEE | 14.47 | 22167270 | |
67 (in isoform 2) | Phosphorylation | - | 14.47 | 18669648 | |
70 | Phosphorylation | EAMNYEGSPIKVTLA ECCCCCCCCEEEEEE | 16.12 | 29255136 | |
70 (in isoform 2) | Phosphorylation | - | 16.12 | 18669648 | |
73 | 2-Hydroxyisobutyrylation | NYEGSPIKVTLATLK CCCCCCEEEEEEEEE | 32.33 | - | |
73 | Acetylation | NYEGSPIKVTLATLK CCCCCCEEEEEEEEE | 32.33 | 26051181 | |
73 | Sumoylation | NYEGSPIKVTLATLK CCCCCCEEEEEEEEE | 32.33 | - | |
73 | Ubiquitination | NYEGSPIKVTLATLK CCCCCCEEEEEEEEE | 32.33 | - | |
75 | O-linked_Glycosylation | EGSPIKVTLATLKMS CCCCEEEEEEEEEEE | 12.98 | 23301498 | |
75 | Phosphorylation | EGSPIKVTLATLKMS CCCCEEEEEEEEEEE | 12.98 | 22167270 | |
75 (in isoform 2) | Phosphorylation | - | 12.98 | 18669648 | |
78 | Phosphorylation | PIKVTLATLKMSVQP CEEEEEEEEEEEECC | 29.98 | 22167270 | |
78 (in isoform 2) | Phosphorylation | - | 29.98 | 18669648 | |
80 | Ubiquitination | KVTLATLKMSVQPTV EEEEEEEEEEECCEE | 25.44 | - | |
80 (in isoform 2) | Ubiquitination | - | 25.44 | - | |
81 | Sulfoxidation | VTLATLKMSVQPTVS EEEEEEEEEECCEEE | 5.51 | 28183972 | |
82 | Phosphorylation | TLATLKMSVQPTVSL EEEEEEEEECCEEEE | 18.93 | 29255136 | |
86 | Phosphorylation | LKMSVQPTVSLGGFE EEEEECCEEEECCEE | 12.97 | 29255136 | |
88 | O-linked_Glycosylation | MSVQPTVSLGGFEIT EEECCEEEECCEEEC | 24.63 | 23301498 | |
88 | Phosphorylation | MSVQPTVSLGGFEIT EEECCEEEECCEEEC | 24.63 | 29255136 | |
88 (in isoform 2) | Phosphorylation | - | 24.63 | 18220336 | |
95 | Phosphorylation | SLGGFEITPPVVLRL EECCEEECCCEEEEE | 17.84 | 25159151 | |
95 (in isoform 2) | Phosphorylation | - | 17.84 | 18669648 | |
101 | Methylation | ITPPVVLRLKCGSGP ECCCEEEEEEECCCC | 22.08 | 116265613 | |
106 | O-linked_Glycosylation | VLRLKCGSGPVHISG EEEEEECCCCEEECC | 49.77 | 23301498 | |
106 | Phosphorylation | VLRLKCGSGPVHISG EEEEEECCCCEEECC | 49.77 | 23927012 | |
112 | O-linked_Glycosylation | GSGPVHISGQHLVAV CCCCEEECCEEEEEE | 19.95 | 23301498 | |
112 | Phosphorylation | GSGPVHISGQHLVAV CCCCEEECCEEEEEE | 19.95 | 23927012 | |
125 | O-linked_Glycosylation | AVEEDAESEDEEEED EEECCCCCCCCHHHH | 52.66 | 23301498 | |
125 | Phosphorylation | AVEEDAESEDEEEED EEECCCCCCCCHHHH | 52.66 | 29255136 | |
125 (in isoform 2) | Phosphorylation | - | 52.66 | 18669648 | |
134 | Sumoylation | DEEEEDVKLLSISGK CCHHHHEEEEEEECC | 56.91 | - | |
135 | Phosphorylation | EEEEDVKLLSISGKR CHHHHEEEEEEECCC | 4.57 | - | |
137 | Phosphorylation | EEDVKLLSISGKRSA HHHEEEEEEECCCCC | 25.74 | 23927012 | |
137 (in isoform 2) | Phosphorylation | - | 25.74 | 18669648 | |
138 | Phosphorylation | EDVKLLSISGKRSAP HHEEEEEEECCCCCC | 6.76 | - | |
139 | Phosphorylation | DVKLLSISGKRSAPG HEEEEEEECCCCCCC | 34.58 | 22167270 | |
139 (in isoform 2) | Phosphorylation | - | 34.58 | 18669648 | |
141 | Ubiquitination | KLLSISGKRSAPGGG EEEEEECCCCCCCCC | 36.07 | 21890473 | |
141 | Sumoylation | KLLSISGKRSAPGGG EEEEEECCCCCCCCC | 36.07 | - | |
141 | 2-Hydroxyisobutyrylation | KLLSISGKRSAPGGG EEEEEECCCCCCCCC | 36.07 | - | |
141 | Acetylation | KLLSISGKRSAPGGG EEEEEECCCCCCCCC | 36.07 | 23954790 | |
141 | Malonylation | KLLSISGKRSAPGGG EEEEEECCCCCCCCC | 36.07 | 26320211 | |
141 | Methylation | KLLSISGKRSAPGGG EEEEEECCCCCCCCC | 36.07 | 68493 | |
141 | Sumoylation | KLLSISGKRSAPGGG EEEEEECCCCCCCCC | 36.07 | 28112733 | |
141 | Ubiquitination | KLLSISGKRSAPGGG EEEEEECCCCCCCCC | 36.07 | 21890473 | |
141 (in isoform 1) | Ubiquitination | - | 36.07 | 21890473 | |
141 (in isoform 2) | Ubiquitination | - | 36.07 | 21890473 | |
141 | Ubiquitination | KLLSISGKRSAPGGG EEEEEECCCCCCCCC | 36.07 | 21890473 | |
143 | Phosphorylation | LSISGKRSAPGGGSK EEEECCCCCCCCCCC | 42.15 | 22617229 | |
149 | Phosphorylation | RSAPGGGSKVPQKKV CCCCCCCCCCCHHHE | 33.48 | 26657352 | |
150 | Sumoylation | SAPGGGSKVPQKKVK CCCCCCCCCCHHHEE | 62.30 | - | |
150 | 2-Hydroxyisobutyrylation | SAPGGGSKVPQKKVK CCCCCCCCCCHHHEE | 62.30 | - | |
150 | Acetylation | SAPGGGSKVPQKKVK CCCCCCCCCCHHHEE | 62.30 | 16916647 | |
150 | Sumoylation | SAPGGGSKVPQKKVK CCCCCCCCCCHHHEE | 62.30 | 28112733 | |
150 | Ubiquitination | SAPGGGSKVPQKKVK CCCCCCCCCCHHHEE | 62.30 | 19608861 | |
152 | Phosphorylation | PGGGSKVPQKKVKLA CCCCCCCCHHHEEEC | 43.97 | - | |
154 | Acetylation | GGSKVPQKKVKLAAD CCCCCCHHHEEECCC | 54.16 | 16916647 | |
155 | Acetylation | GSKVPQKKVKLAADE CCCCCHHHEEECCCC | 39.08 | 7303085 | |
155 | Ubiquitination | GSKVPQKKVKLAADE CCCCCHHHEEECCCC | 39.08 | 21906983 | |
155 (in isoform 1) | Ubiquitination | - | 39.08 | 21890473 | |
155 (in isoform 2) | Ubiquitination | - | 39.08 | 21890473 | |
156 | Phosphorylation | SKVPQKKVKLAADED CCCCHHHEEECCCCC | 8.71 | - | |
157 | Acetylation | KVPQKKVKLAADEDD CCCHHHEEECCCCCC | 41.09 | 26051181 | |
157 | Ubiquitination | KVPQKKVKLAADEDD CCCHHHEEECCCCCC | 41.09 | 21906983 | |
157 (in isoform 1) | Ubiquitination | - | 41.09 | 21890473 | |
157 (in isoform 2) | Ubiquitination | - | 41.09 | 21890473 | |
164 | Phosphorylation | KLAADEDDDDDDEED EECCCCCCCCCCCCC | 60.22 | - | |
189 | Acetylation | DDEEAEEKAPVKKSI CHHHHHHHCCCCHHH | 49.88 | 26051181 | |
189 | Ubiquitination | DDEEAEEKAPVKKSI CHHHHHHHCCCCHHH | 49.88 | 1890473 | |
189 (in isoform 1) | Ubiquitination | - | 49.88 | 21890473 | |
189 (in isoform 2) | Ubiquitination | - | 49.88 | 21890473 | |
191 | Phosphorylation | EEAEEKAPVKKSIRD HHHHHHCCCCHHHCC | 49.91 | - | |
193 | Acetylation | AEEKAPVKKSIRDTP HHHHCCCCHHHCCCH | 39.48 | 26051181 | |
193 | Ubiquitination | AEEKAPVKKSIRDTP HHHHCCCCHHHCCCH | 39.48 | 21906983 | |
193 (in isoform 1) | Ubiquitination | - | 39.48 | 21890473 | |
193 (in isoform 2) | Ubiquitination | - | 39.48 | 21890473 | |
195 | Phosphorylation | EKAPVKKSIRDTPAK HHCCCCHHHCCCHHH | 19.69 | 30266825 | |
197 | Methylation | APVKKSIRDTPAKNA CCCCHHHCCCHHHHH | 49.17 | 115485495 | |
198 (in isoform 2) | Phosphorylation | - | 56.20 | 20068231 | |
199 | Phosphorylation | VKKSIRDTPAKNAQK CCHHHCCCHHHHHHH | 18.46 | 23927012 | |
202 | Sumoylation | SIRDTPAKNAQKSNQ HHCCCHHHHHHHHCC | 54.76 | - | |
202 | Acetylation | SIRDTPAKNAQKSNQ HHCCCHHHHHHHHCC | 54.76 | 19666589 | |
202 | Sumoylation | SIRDTPAKNAQKSNQ HHCCCHHHHHHHHCC | 54.76 | - | |
202 | Ubiquitination | SIRDTPAKNAQKSNQ HHCCCHHHHHHHHCC | 54.76 | 21906983 | |
202 (in isoform 1) | Ubiquitination | - | 54.76 | 21890473 | |
207 | ADP-ribosylation | PAKNAQKSNQNGKDS HHHHHHHHCCCCCCC | 31.41 | 28190768 | |
207 | Phosphorylation | PAKNAQKSNQNGKDS HHHHHHHHCCCCCCC | 31.41 | 26074081 | |
208 (in isoform 2) | Phosphorylation | - | 46.50 | 25159151 | |
212 | Acetylation | QKSNQNGKDSKPSST HHHCCCCCCCCCCCC | 67.39 | 16916647 | |
212 | Succinylation | QKSNQNGKDSKPSST HHHCCCCCCCCCCCC | 67.39 | 23954790 | |
214 | Phosphorylation | SNQNGKDSKPSSTPR HCCCCCCCCCCCCCC | 50.37 | 21601212 | |
215 | Sumoylation | NQNGKDSKPSSTPRS CCCCCCCCCCCCCCH | 60.08 | - | |
215 | Acetylation | NQNGKDSKPSSTPRS CCCCCCCCCCCCCCH | 60.08 | 23954790 | |
215 | Sumoylation | NQNGKDSKPSSTPRS CCCCCCCCCCCCCCH | 60.08 | 28112733 | |
217 | Phosphorylation | NGKDSKPSSTPRSKG CCCCCCCCCCCCHHH | 51.05 | 25159151 | |
218 | Phosphorylation | GKDSKPSSTPRSKGQ CCCCCCCCCCCHHHH | 51.46 | 30278072 | |
219 | Phosphorylation | KDSKPSSTPRSKGQE CCCCCCCCCCHHHHH | 27.36 | 30278072 | |
219 (in isoform 2) | Ubiquitination | - | 27.36 | 21890473 | |
221 (in isoform 2) | Ubiquitination | - | 51.60 | 21890473 | |
222 | Phosphorylation | KPSSTPRSKGQESFK CCCCCCCHHHHHHHH | 42.20 | 30576142 | |
223 | Sumoylation | PSSTPRSKGQESFKK CCCCCCHHHHHHHHC | 66.93 | - | |
223 | 2-Hydroxyisobutyrylation | PSSTPRSKGQESFKK CCCCCCHHHHHHHHC | 66.93 | - | |
223 | Acetylation | PSSTPRSKGQESFKK CCCCCCHHHHHHHHC | 66.93 | 23749302 | |
223 | Sumoylation | PSSTPRSKGQESFKK CCCCCCHHHHHHHHC | 66.93 | - | |
223 | Ubiquitination | PSSTPRSKGQESFKK CCCCCCHHHHHHHHC | 66.93 | - | |
227 | Phosphorylation | PRSKGQESFKKQEKT CCHHHHHHHHCCCCC | 34.18 | 23401153 | |
228 (in isoform 2) | Ubiquitination | - | 12.94 | 21890473 | |
229 | Sumoylation | SKGQESFKKQEKTPK HHHHHHHHCCCCCCC | 63.93 | - | |
229 | 2-Hydroxyisobutyrylation | SKGQESFKKQEKTPK HHHHHHHHCCCCCCC | 63.93 | - | |
229 | Acetylation | SKGQESFKKQEKTPK HHHHHHHHCCCCCCC | 63.93 | 16107701 | |
229 | Succinylation | SKGQESFKKQEKTPK HHHHHHHHCCCCCCC | 63.93 | 23954790 | |
229 | Sumoylation | SKGQESFKKQEKTPK HHHHHHHHCCCCCCC | 63.93 | 16107701 | |
229 | Ubiquitination | SKGQESFKKQEKTPK HHHHHHHHCCCCCCC | 63.93 | - | |
230 | Sumoylation | KGQESFKKQEKTPKT HHHHHHHCCCCCCCC | 62.77 | - | |
230 | Acetylation | KGQESFKKQEKTPKT HHHHHHHCCCCCCCC | 62.77 | 16107701 | |
230 | Sumoylation | KGQESFKKQEKTPKT HHHHHHHCCCCCCCC | 62.77 | 25114211 | |
234 | Phosphorylation | SFKKQEKTPKTPKGP HHHCCCCCCCCCCCC | 29.30 | 20201521 | |
237 | Phosphorylation | KQEKTPKTPKGPSSV CCCCCCCCCCCCCCH | 31.28 | 20201521 | |
238 (in isoform 2) | Ubiquitination | - | 45.81 | 21890473 | |
239 | Sumoylation | EKTPKTPKGPSSVED CCCCCCCCCCCCHHH | 84.45 | - | |
239 | 2-Hydroxyisobutyrylation | EKTPKTPKGPSSVED CCCCCCCCCCCCHHH | 84.45 | - | |
239 | Acetylation | EKTPKTPKGPSSVED CCCCCCCCCCCCHHH | 84.45 | 26051181 | |
239 | Malonylation | EKTPKTPKGPSSVED CCCCCCCCCCCCHHH | 84.45 | 26320211 | |
239 | Succinylation | EKTPKTPKGPSSVED CCCCCCCCCCCCHHH | 84.45 | 23954790 | |
239 | Sumoylation | EKTPKTPKGPSSVED CCCCCCCCCCCCHHH | 84.45 | - | |
239 | Ubiquitination | EKTPKTPKGPSSVED CCCCCCCCCCCCHHH | 84.45 | - | |
242 | Phosphorylation | PKTPKGPSSVEDIKA CCCCCCCCCHHHHHH | 56.54 | 29255136 | |
243 | Phosphorylation | KTPKGPSSVEDIKAK CCCCCCCCHHHHHHH | 32.43 | 29255136 | |
243 (in isoform 3) | Phosphorylation | - | 32.43 | 25849741 | |
244 (in isoform 2) | Ubiquitination | - | 10.07 | 21890473 | |
248 | Sumoylation | PSSVEDIKAKMQASI CCCHHHHHHHHHHHH | 55.03 | - | |
248 | Acetylation | PSSVEDIKAKMQASI CCCHHHHHHHHHHHH | 55.03 | 23749302 | |
248 | Malonylation | PSSVEDIKAKMQASI CCCHHHHHHHHHHHH | 55.03 | 30639696 | |
248 | Methylation | PSSVEDIKAKMQASI CCCHHHHHHHHHHHH | 55.03 | 72662745 | |
248 | Sumoylation | PSSVEDIKAKMQASI CCCHHHHHHHHHHHH | 55.03 | 28112733 | |
248 | Ubiquitination | PSSVEDIKAKMQASI CCCHHHHHHHHHHHH | 55.03 | 21906983 | |
248 (in isoform 1) | Ubiquitination | - | 55.03 | 21890473 | |
250 | Sumoylation | SVEDIKAKMQASIEK CHHHHHHHHHHHHHC | 26.92 | - | |
250 | 2-Hydroxyisobutyrylation | SVEDIKAKMQASIEK CHHHHHHHHHHHHHC | 26.92 | - | |
250 | Acetylation | SVEDIKAKMQASIEK CHHHHHHHHHHHHHC | 26.92 | 16107701 | |
250 | Sumoylation | SVEDIKAKMQASIEK CHHHHHHHHHHHHHC | 26.92 | 28112733 | |
250 | Ubiquitination | SVEDIKAKMQASIEK CHHHHHHHHHHHHHC | 26.92 | 21906983 | |
250 (in isoform 1) | Ubiquitination | - | 26.92 | 21890473 | |
254 | Phosphorylation | IKAKMQASIEKGGSL HHHHHHHHHHCCCCC | 17.87 | 29255136 | |
254 (in isoform 3) | Phosphorylation | - | 17.87 | 26055452 | |
257 | Acetylation | KMQASIEKGGSLPKV HHHHHHHCCCCCCHH | 67.89 | 19608861 | |
257 | Malonylation | KMQASIEKGGSLPKV HHHHHHHCCCCCCHH | 67.89 | 26320211 | |
257 | Sumoylation | KMQASIEKGGSLPKV HHHHHHHCCCCCCHH | 67.89 | 19608861 | |
257 | Ubiquitination | KMQASIEKGGSLPKV HHHHHHHCCCCCCHH | 67.89 | 21906983 | |
257 (in isoform 1) | Ubiquitination | - | 67.89 | 21890473 | |
257 (in isoform 3) | Acetylation | - | 67.89 | 19608861 | |
260 | Phosphorylation | ASIEKGGSLPKVEAK HHHHCCCCCCHHHHH | 50.60 | 23927012 | |
263 | Sumoylation | EKGGSLPKVEAKFIN HCCCCCCHHHHHHHH | 58.98 | - | |
263 | Acetylation | EKGGSLPKVEAKFIN HCCCCCCHHHHHHHH | 58.98 | 26051181 | |
263 | Sumoylation | EKGGSLPKVEAKFIN HCCCCCCHHHHHHHH | 58.98 | 15897463 | |
263 | Ubiquitination | EKGGSLPKVEAKFIN HCCCCCCHHHHHHHH | 58.98 | - | |
267 | Ubiquitination | SLPKVEAKFINYVKN CCCHHHHHHHHHHHH | 33.02 | 21890473 | |
267 | Sumoylation | SLPKVEAKFINYVKN CCCHHHHHHHHHHHH | 33.02 | - | |
267 | Acetylation | SLPKVEAKFINYVKN CCCHHHHHHHHHHHH | 33.02 | 19608861 | |
267 | Malonylation | SLPKVEAKFINYVKN CCCHHHHHHHHHHHH | 33.02 | 30639696 | |
267 | Succinylation | SLPKVEAKFINYVKN CCCHHHHHHHHHHHH | 33.02 | 23954790 | |
267 | Sumoylation | SLPKVEAKFINYVKN CCCHHHHHHHHHHHH | 33.02 | 19608861 | |
267 | Ubiquitination | SLPKVEAKFINYVKN CCCHHHHHHHHHHHH | 33.02 | 21890473 | |
267 (in isoform 1) | Ubiquitination | - | 33.02 | 21890473 | |
273 | Ubiquitination | AKFINYVKNCFRMTD HHHHHHHHHHHHCCC | 37.32 | 21890473 | |
273 | 2-Hydroxyisobutyrylation | AKFINYVKNCFRMTD HHHHHHHHHHHHCCC | 37.32 | - | |
273 | Acetylation | AKFINYVKNCFRMTD HHHHHHHHHHHHCCC | 37.32 | 19608861 | |
273 | Malonylation | AKFINYVKNCFRMTD HHHHHHHHHHHHCCC | 37.32 | 26320211 | |
273 | Methylation | AKFINYVKNCFRMTD HHHHHHHHHHHHCCC | 37.32 | 68521 | |
273 | Succinylation | AKFINYVKNCFRMTD HHHHHHHHHHHHCCC | 37.32 | 23954790 | |
273 | Sumoylation | AKFINYVKNCFRMTD HHHHHHHHHHHHCCC | 37.32 | 28112733 | |
273 | Ubiquitination | AKFINYVKNCFRMTD HHHHHHHHHHHHCCC | 37.32 | 21890473 | |
273 (in isoform 1) | Ubiquitination | - | 37.32 | 21890473 | |
278 | Sulfoxidation | YVKNCFRMTDQEAIQ HHHHHHHCCCHHHHH | 2.13 | 30846556 | |
279 | Phosphorylation | VKNCFRMTDQEAIQD HHHHHHCCCHHHHHH | 30.21 | 25159151 | |
292 | Acetylation | QDLWQWRKSL----- HHHHHHHHHC----- | 53.82 | 16107701 | |
292 | Sumoylation | QDLWQWRKSL----- HHHHHHHHHC----- | 53.82 | 16107701 | |
293 | Phosphorylation | DLWQWRKSL------ HHHHHHHHC------ | 30.64 | 29496963 | |
338 | Phosphorylation | --------------------------------------------------- --------------------------------------------------- | - | ||
342 | Phosphorylation | ------------------------------------------------------- ------------------------------------------------------- | - | ||
343 | Phosphorylation | -------------------------------------------------------- -------------------------------------------------------- | - | ||
419 | Phosphorylation | ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ | - | ||
497 | Phosphorylation | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | - | ||
567 | Phosphorylation | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | - | ||
644 | Phosphorylation | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | - | ||
664 | Phosphorylation | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
4 | S | Phosphorylation | Kinase | PLK3 | Q9H4B4 | PSP |
4 | S | Phosphorylation | Kinase | PLK2 | Q9NYY3 | Uniprot |
4 | S | Phosphorylation | Kinase | PLK1 | P53350 | Uniprot |
48 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
70 | S | Phosphorylation | Kinase | NEK2 | P51955 | PSP |
70 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
70 | S | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
88 | S | Phosphorylation | Kinase | NEK2 | P51955 | PSP |
125 | S | Phosphorylation | Kinase | ATR | Q13535 | PSP |
125 | S | Phosphorylation | Kinase | AURA | O14965 | PSP |
125 | S | Phosphorylation | Kinase | AURB | Q96GD4 | PSP |
125 | S | Phosphorylation | Kinase | CDK2 | P24941 | Uniprot |
125 | S | Phosphorylation | Kinase | CK2A1 | P68400 | PSP |
137 | S | Phosphorylation | Kinase | CDC7 | O00311 | PSP |
199 | T | Phosphorylation | Kinase | CDK2 | P24941 | Uniprot |
199 | T | Phosphorylation | Kinase | MAP3K8 | P41279 | GPS |
199 | T | Phosphorylation | Kinase | CDK6 | Q00534 | Uniprot |
199 | T | Phosphorylation | Kinase | CDK1 | P06493 | Uniprot |
199 | T | Phosphorylation | Kinase | CDC7 | O00311 | PSP |
219 | T | Phosphorylation | Kinase | CDK1 | P06493 | Uniprot |
227 | S | Phosphorylation | Kinase | PKC-FAMILY | - | GPS |
227 | S | Phosphorylation | Kinase | PKC_GROUP | - | PhosphoELM |
234 | T | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
234 | T | Phosphorylation | Kinase | CDK1 | P06493 | Uniprot |
237 | T | Phosphorylation | Kinase | CDK1 | P06493 | Uniprot |
- | K | Ubiquitination | E3 ubiquitin ligase | STUB1 | Q9UNE7 | PMID:15126367 |
- | K | Ubiquitination | E3 ubiquitin ligase | BRCA1 | P38398 | PMID:15184379 |
- | K | Ubiquitination | E3 ubiquitin ligase | RNF144B | Q7Z419 | PMID:20864535 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
4 | S | Phosphorylation |
| 15388344 |
4 | S | Phosphorylation |
| 15388344 |
4 | S | Phosphorylation |
| 15388344 |
70 | S | Phosphorylation |
| 15388344 |
125 | S | Phosphorylation |
| 15388344 |
199 | T | Phosphorylation |
| 15388344 |
199 | T | Phosphorylation |
| 15388344 |
199 | T | Phosphorylation |
| 15388344 |
199 | T | Phosphorylation |
| 15388344 |
199 | T | Phosphorylation |
| 15388344 |
219 | T | Phosphorylation |
| 15388344 |
234 | T | Phosphorylation |
| 15388344 |
237 | T | Phosphorylation |
| 15388344 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NPM_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-4; SER-10; THR-95; SER-125; SER-139 ANDSER-254, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-32; LYS-150; LYS-257;LYS-267 AND LYS-273, AND MASS SPECTROMETRY. | |
"Substrate and functional diversity of lysine acetylation revealed bya proteomics survey."; Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.; Mol. Cell 23:607-618(2006). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-150; LYS-154 AND LYS-212,AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Polo-like kinase 2-dependent phosphorylation of NPM/B23 on serine 4triggers centriole duplication."; Krause A., Hoffmann I.; PLoS ONE 5:E9849-E9849(2010). Cited for: FUNCTION, PHOSPHORYLATION AT SER-4 BY PLK2, AND MUTAGENESIS OF SER-4;THR-95; SER-125 AND THR-199. | |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-70 AND SER-125, AND MASSSPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-106 AND SER-125, ANDMASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-4; SER-10; THR-95; SER-125; SER-139 ANDSER-254, AND MASS SPECTROMETRY. | |
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography."; Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.; Proteomics 8:1346-1361(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-70; THR-75; THR-95;SER-125; SER-139; THR-234; THR-237; SER-243; SER-254; SER-260 ANDTHR-279, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-70; SER-125 AND SER-254,AND MASS SPECTROMETRY. | |
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment."; Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.; J. Proteome Res. 7:5167-5176(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-70; SER-88; SER-125 ANDTHR-279, AND MASS SPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10; SER-70; SER-125;SER-243; SER-254 AND SER-260, AND MASS SPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-70; SER-125; SER-137;THR-199; THR-234; THR-237 AND SER-260, AND MASS SPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-70; THR-75; THR-95;SER-137; THR-199; SER-254 AND SER-260, AND MASS SPECTROMETRY. | |
"Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-70; SER-125 AND SER-254,AND MASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4; SER-10; SER-70;THR-95; THR-199 AND SER-254, AND MASS SPECTROMETRY. | |
"B23/nucleophosmin serine 4 phosphorylation mediates mitotic functionsof polo-like kinase 1."; Zhang H., Shi X., Paddon H., Hampong M., Dai W., Pelech S.; J. Biol. Chem. 279:35726-35734(2004). Cited for: PHOSPHORYLATION AT SER-4 BY PLK1. | |
"Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHVlatency."; Sarek G., Jaerviluoma A., Moore H.M., Tojkander S., Vartia S.,Biberfeld P., Laiho M., Ojala P.M.; PLoS Pathog. 6:E1000818-E1000818(2010). Cited for: PHOSPHORYLATION AT THR-199 BY CDK6. | |
"Global phosphoproteome of HT-29 human colon adenocarcinoma cells."; Kim J.-E., Tannenbaum S.R., White F.M.; J. Proteome Res. 4:1339-1346(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-199, AND MASSSPECTROMETRY. | |
Sumoylation | |
Reference | PubMed |
"Sumoylation induced by the Arf tumor suppressor: a p53-independentfunction."; Tago K., Chiocca S., Sherr C.J.; Proc. Natl. Acad. Sci. U.S.A. 102:7689-7694(2005). Cited for: SUMOYLATION AT LYS-230 AND LYS-263. |